Search results
Jump to navigation
Jump to search
- | pagename = Peripheral vascular disease | abc = Peripheral vascular disease2 KB (233 words) - 09:13, 7 January 2009
- ===Prediction vascular disease and mortality===3 KB (418 words) - 13:21, 15 February 2009
- {{r|Vascular disease}}487 bytes (61 words) - 10:58, 11 January 2010
- {{r|Vascular disease}}515 bytes (67 words) - 18:28, 11 January 2010
- {{r|Vascular disease}}1 KB (153 words) - 17:20, 11 January 2010
- {{r|Peripheral vascular disease}}481 bytes (62 words) - 21:28, 11 January 2010
- {{r|Vascular disease}}591 bytes (74 words) - 16:33, 11 January 2010
- {{r|Vascular disease}}686 bytes (93 words) - 10:58, 11 January 2010
- ...Kaptoge S, Ray KK et al.| title=Major lipids, apolipoproteins, and risk of vascular disease. | journal=JAMA | year= 2009 | volume= 302 | issue= 18 | pages= 1993-2000 |2 KB (299 words) - 01:31, 21 September 2010
- ...blood vessels, drugs that contract the painful vessels, with due care for vascular disease that may increase risk, are disease-modifying. In the past, [[ergotamine]]1 KB (207 words) - 08:22, 2 May 2010
- ===Vascular disease=== {{main|Vascular disease}}5 KB (688 words) - 21:20, 2 September 2011
- {{r|Vascular disease}}812 bytes (102 words) - 19:58, 11 January 2010
- {{r|Vascular disease}}2 KB (310 words) - 12:22, 18 April 2024
- {{r|Vascular disease}}3 KB (366 words) - 12:22, 18 April 2024
- ...arge enough for the presence of hyperuricemia to help in the prediction of vascular disease.<ref name="pmid15783260">{{cite journal |author=Wheeler JG, Juzwishin KD, E6 KB (819 words) - 22:44, 13 July 2010
- ...[[chemoprevention]] with [[aspirin]] for the [[primary prevention]] of [[vascular disease]].<ref name="pmid3125882">{{cite journal| author=Peto R, Gray R, Collins R,2 KB (242 words) - 21:10, 22 August 2010
- ...supplementation may actually be harmful when used for the prevention of [[vascular disease]].<ref name="pmid15537682">{{cite journal |author=Miller ER, Pastor-Barri1 KB (193 words) - 03:28, 6 January 2011
- ...beta-synthase]] and is a risk factor for [[coronary heart disease|coronary vascular disease]]."<ref>{{MeSH|Hyperhomocysteinemia}}</ref><ref name="OMIM - Hyperhomocyste ...fman JS, ''et al'' |title=Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomize8 KB (1,016 words) - 10:28, 2 November 2009
- ===Vascular disease prevention=== ...005758 |issn=}}</ref> and [[vitamin E]] (α-tocopherol) and reductions in [[vascular disease]].<ref name="pmid8479463">{{cite journal |author=Stampfer MJ, Hennekens CH,9 KB (1,254 words) - 01:42, 23 May 2009
- ...Ib-IIIa complex and inhibit platelet aggregation. They arp used to treat [[vascular disease]]s.2 KB (291 words) - 21:55, 14 February 2010